# eTheRNA immunotherapies: Biotechnology, Niel, Belgium

> eTheRNA immunotherapies: eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.

Source: https://millionrounds.com/startup/etherna-immunotherapies (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Biotechnology startup](https://millionrounds.com/companies)

# eTheRNA immunotherapies

eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.

Funding reported Last round: Series B

Biotechnology Niel, Belgium

Company summary

- **Founded:** 2013 13 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** 111.9M as listed, currency not stated
- **Last round:** Series B Aug 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for eTheRNA immunotherapies has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say eTheRNA immunotherapies raised

Funding, as reported

Reported in all **111.9M** in the source's currency

Rounds **5**

Last round **Series B**

Last round date **Aug 2022**

Investors listed **14**

## Founders and team

From eTheRNA immunotherapies's own website: 5 on the team.

- **Bernard Sagaert** Chief Executive Officer
- **Philip Van der Auwera** VP HR & Operations
- **Stefaan De Koker** VP Technology & Innovation
- **Florence Lambolez** Director Pharmacology
- **Lien Vangansewinkel** Finance Director

## On a portfolio page

Investors who name them

- [Fund+](https://millionrounds.com/fund/fundplus)

Each firm lists eTheRNA immunotherapies on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in Belgium

Startups like it

- [**Ra Pharmaceuticals** founded 2008](https://millionrounds.com/startup/ra-pharmaceuticals)
- [**ExeVir Bio** Zwijnaarde · founded 2020](https://millionrounds.com/startup/exevir-bio)
- [**Mycorena** Gothenburg · founded 2017](https://millionrounds.com/startup/mycorena)
- [**Complix** Diepenbeek · founded 2008](https://millionrounds.com/startup/complix)
- [**Rewind Therapeutics** Leuven · founded 2017](https://millionrounds.com/startup/rewind-therapeutics)
- [**Inbiose** Ghent · founded 2013](https://millionrounds.com/startup/inbiose)
- [**UgenTec** Hasselt · founded 2014](https://millionrounds.com/startup/ugentec)
- [**Ovizio** Brussels · founded 2010](https://millionrounds.com/startup/ovizio)

## Is this your company?

Add your raise, your deck and your story, and put eTheRNA immunotherapies in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)